Non-opioid drug products for pain management

This list is intended for informational purposes only and not intended to be either complete or to be used as guidance for opioid substitution.

Section 4 of Chapter 52 of the Acts of 2016, An Act relative to substance use, treatment, education and prevention, amends section 13 of chapter 17 of the General Laws to require the Drug Formulary Commission, by September 1, 2016, to publish, distribute, and update annually a list of FDA approved, non-opioid drug products that are effective paindrug products management alternatives and have a lesser potential for abuse than Schedule II and III opioid drug products.

List, as approved by the Drug Formulary Commission on September 11, 2017

Feedback

Tell us what you think